1-10 of 10
Keywords: Domperidone
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Neuroendocrinology (1992) 56 (5): 704–711.
Published Online: 07 April 2008
..., domperidone (DOM). After withdrawal of blood from pregnant rats on day 7 in order to demonstrate the presence of a PRL surge, experimental rats received DOM (100 µg/kg i.v. or i.a.) at various times on day 8. Blood samples were taken immediately before and following injection of DOM at 5, 15, 30 and 60 min...
Journal Articles
Neuroendocrinology (1991) 53 (5): 503–510.
Published Online: 04 April 2008
... with a highly specific antiserum abolished the increases in OT in response to either suckling or to administration of the D-2 dopamine antagonist domperidone. These findings suggest that (1) an action of PRL released by suckling may be of physiological importance in promoting the release of OT in lactating rats...
Journal Articles
Journal Articles
Journal Articles
Neuroendocrinology (1987) 45 (3): 243–247.
Published Online: 02 April 2008
... agonist, bromocriptine, and a dopamine antagonist, domperidone, as well as a muscarinic cholinergic antagonist, pirenzepine, on the GH response to an analogue of GH-releasing hormone (GHRH) in normal male subjects. GHRH(1–29)NH 2 induced a rise in serum GH that was augmented by bromocriptine, antagonized...
Journal Articles
Neuroendocrinology (1989) 49 (4): 428–433.
Published Online: 02 April 2008
... that the dopaminergic blocker domperidone inhibited apomorphine-induced ACTH release if permeability of the BBB was increased, but not under normal conditions. It is suggested that the changes in BBB function can modify the neuroendocrine response also to other circulating substances and this may be an important, until...
Journal Articles
Journal Articles
Neuroendocrinology (1980) 30 (2): 65–69.
Published Online: 26 March 2008
...D. Cocchi; I. Gil-Ad; M. Parenti; E. Stefanini; V. Locatelli; E.E. Müller The prolactin (PRL)-releasing effect of domperidone (DOM), a blocker of dopamine receptors which does not cross the blood-brain barrier, was studied in unanesthetized male rats and compared to that of the classic neuroleptic...
Journal Articles
Neuroendocrinology (1982) 35 (3): 186–193.
Published Online: 26 March 2008
...D.J. Bailey; J. Herbert Sexually experienced male CFHB rats, castrated and implanted with testosterone, were chronically treated with domperidone (ca. 5 mg/kg/day). Twice-weekly tests of sexual behaviour showed a significant elevation of both mount latency and ejaculation latency, and suppression...
Journal Articles
Neuroendocrinology (1980) 30 (1): 2–6.
Published Online: 26 March 2008
...F. Camanni; A.R. Genazzani; F. Massara; R. La Rosa; D. Cocchi; Eugenio E. Müller The prolactin (PRL)-releasing effect of domperidone (DOM), a novel antidopaminergic drug which does not cross the blood-brain barrier, was investigated in normoprolactinemic subjects, in subjects with physiologic...